A device having a channel with a sequence of compartments having molecules having specific binding sites, this sequence of compartments being suitable for the specific binding of analytes, characterized in that the molecules having specific binding sites are bound to porous cryogels as carriers and the cryogels are chemically bonded to the wall of the channel, a method for producing the device and the use of the device in analytics.

An embodiment of the present disclosure is a sample collection unit configured to receive a test strip. The sample collection unit includes a collection tube including an open end and a cap configured to be coupled to the open end to close the collection tube. The cap includes an access opening that extends through the cap and at least one sealing member aligned with the access opening. The at least one sealing member includes a dynamic strip interface that permits insertion of the test strip through the access opening and into the collection tube.

The disclosure provides three-dimensional cross-linked polymer networks transport channels, arrays comprising the networks, processes for making the networks, and uses of the networks and arrays.

Provided herein are epidermal microfluidic systems and methods that allow for the collection of biofluids in a wet or aquatic environment, for example, from the surface of the skin. The described systems allow for the efficient collection of biofluids, without loss of the biofluid to the surrounding environment or introduction of extraneous liquids from the environment. The described microfluidic systems are versatile and can provide information regarding a number of biofluid properties both electronically and colorimetrically/visually.

The present subject matter relates to compounds that have aggregation-induced emission (AIE) characteristics and are capable of generating Raman signals in the Raman cell-silent region (1800 cm.sup.−1-2800 cm.sup.−1). The compounds can be used in dual-mode cell imaging by fluorescence and Raman microscopes

A specimen containing a substance to be measured is introduced into a flow path of a measurement chip including a flow path which is a cavity for accommodating liquid and a reflecting unit which specularly reflects light which passes through the flow path so as to pass through the flow path again and a measurement value indicating an amount of the substance to be measured in the specimen is acquired. Then, second light acquired when first light including light of a wavelength absorbed by a red blood cell passes through the specimen in the flow path, is reflected by the reflecting unit, and passes through the specimen in the flow path again is detected in a state in which the specimen is present in the flow path. Next, a hematocrit value of the specimen is determined on the basis of a detection result of the second light. Next, a measurement value is corrected on the basis of the hematocrit value.

A membrane carrier for a liquid sample test kit that detects a substance to be detected in a liquid sample, the membrane carrier including at least one integrally-molded flow path capable of transporting the liquid sample, in which a microstructure that causes a capillary action for transporting the liquid sample is provided on a bottom surface of the flow path, and the microstructure has two or more peak positions at which a height becomes maximum per one repeating unit structure.

A submersible sensor device configured as a small pellet for testing biological and other liquid samples is provided. In one aspect, a sensing device includes: a housing; and one or more sensors contained within the housing, wherein the housing hermetically seals the sensors such that the sensing device is fully submersible in a liquid analyte. A method and system for analysis of a liquid sample using the present sensing device are also provided.

A system for testing a treatment agent for a biologic material includes an input for receiving a biologic sample. A plurality of micro-pumps pump a portion of the biologic sample from the first reservoir into a connected module. A first module includes a first plurality of testing pathways for testing a first portion of the biologic sample. A first module connector removeably connects the first module to the distributor module. A second module includes a second plurality of testing pathways for testing a second portion of the biologic sample. The selected pathway applies at least one dosage level of a treatment agent to the second portion of the biologic sample. A second module connector removeably connects the second module to the distributor module, wherein treatment agent and the plurality of dosage levels tested by the system may be selected by selecting the second module associated with the second module connector.

This disclosure relates to systems and methods for isolating, detecting, and/or analyzing brain-derived cells or particles in the blood circulation of human and animal subjects.